Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: (So, the consensus is)

I think the 2 yr plan and the 5 yr plan HAVE been stated by PTSC/Turley. It is fairly simple. Take the money earned to date on the MMP licensing and acquire/merge with a company that has a positive cash flow position and preferably one with tangible products. In adddition, move the company to a better exchange such as the Amex or the Nasdaq. Possibly, accomplish both goals with one transaction. Continue the plan further by acquiring an additional 1 to 2 companies and merge the resulatang ocmpanies into one new one. All the while, continue to prosecute the MMP trial case/settlement and continue to license the MMP along the way. I think based on what I've heard, interpreted, the 5-yr plan is ultimately PTSC in a different form whereby they are either a holding company for multiple companies, or they are a new larger product producing positve cash flow business enterprise.

Obviously, this hasn't happened yet, but it IS happening, at least if we can believe Turley and the board. I don't see a reason to doubt them, nor do I see a reason to rush them. What would concern me is major cash being taken out of the company via exhorbitant salaries and bonuses, which I do have concern about based on someone's post yesterday re: the BOD salaries, though I can't say I've confirmed that myself.

I don't consider any of this sitting around and waiting for the litigation result. What I do think, though is that the litigation / settlement result may impact that actual M&A process by limiting their abilities to acquire, or by broadening them, based on the outcome.

Share
New Message
Please login to post a reply